FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
| Autor: | Cremolini, Chiara, Loupakis, Fotios, Antoniotti, Carlotta, Lupi, Cristiana, Sensi, Elisa, Lonardi, Sara, Mezi, Silvia, Tomasello, Gianluca, Ronzoni, Monica, Zaniboni, Alberto, Tonini, Giuseppe, Carlomagno, Chiara, Allegrini, Giacomo, Chiara, Silvana, D'Amico, Mauro, Granetto, Cristina, Cazzaniga, Marina, Boni, Luca, Fontanini, Gabriella, Falcone, Alfredo |
|---|---|
| Zdroj: | In The Lancet Oncology October 2015 16(13):1306-1315 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|